| __timestamp | Gilead Sciences, Inc. | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 24890000000 | 75334000 |
| Thursday, January 1, 2015 | 32639000000 | 135057000 |
| Friday, January 1, 2016 | 30390000000 | 146691000 |
| Sunday, January 1, 2017 | 26107000000 | 316613000 |
| Monday, January 1, 2018 | 22127000000 | 151862000 |
| Tuesday, January 1, 2019 | 22449000000 | 195992000 |
| Wednesday, January 1, 2020 | 24689000000 | 267594000 |
| Friday, January 1, 2021 | 27305000000 | 443310000 |
| Saturday, January 1, 2022 | 27281000000 | 660116000 |
| Sunday, January 1, 2023 | 27116000000 | 829253000 |
| Monday, January 1, 2024 | 28754000000 | 1015324000 |
Unveiling the hidden dimensions of data
In the competitive landscape of biotechnology, Gilead Sciences, Inc. and Halozyme Therapeutics, Inc. have been vying for dominance. Over the past decade, Gilead Sciences has consistently outperformed Halozyme in terms of annual revenue. From 2014 to 2023, Gilead's revenue peaked in 2015, reaching nearly 33 billion dollars, while Halozyme's highest revenue was just under 830 million dollars in 2023. This stark contrast highlights Gilead's commanding presence, with revenues averaging over 26 billion dollars annually, compared to Halozyme's 322 million dollars. Despite Halozyme's impressive growth, with a tenfold increase in revenue from 2014 to 2023, Gilead remains the leader. This data underscores the significant scale and market influence Gilead holds in the biotech sector, while Halozyme's growth trajectory suggests a promising future.
Revenue Insights: Johnson & Johnson and Halozyme Therapeutics, Inc. Performance Compared
Revenue Showdown: AstraZeneca PLC vs Gilead Sciences, Inc.
Bristol-Myers Squibb Company and Gilead Sciences, Inc.: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Gilead Sciences, Inc. vs BioMarin Pharmaceutical Inc.
Gilead Sciences, Inc. and Bio-Techne Corporation: A Comprehensive Revenue Analysis
Revenue Showdown: Gilead Sciences, Inc. vs Corcept Therapeutics Incorporated
Who Generates More Revenue? Gilead Sciences, Inc. or Geron Corporation
Revenue Insights: Gilead Sciences, Inc. and Dynavax Technologies Corporation Performance Compared
Gilead Sciences, Inc. and Celldex Therapeutics, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: Gilead Sciences, Inc. vs Galapagos NV
Teva Pharmaceutical Industries Limited or Halozyme Therapeutics, Inc.: Who Leads in Yearly Revenue?
Comparing Revenue Performance: Halozyme Therapeutics, Inc. or HUTCHMED (China) Limited?